HSBC
-
Chinese biopharmaceutical firm taps hot healthcare demand -
-
-
Indian issuers seek listing approval
-
The state-owned lender is readying what could be India's lowest rated offshore AT1
-
Work on a $1bn bond to take out a bridge loan backing Indian IT firm’s potential acquisition is underway
-
UK insurer's 'defensive' investment status made it popular with investors
-
-
-
Loan backing the leveraged buyout of Hinduja Global Solutions’ healthcare unit in general syndication
-
-
